Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 530 participants.

Also called NCT05462730

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 530 participants (enrolled count) (from the registry)
Sponsor
Thomas Engstrom (from the registry)
Registry
  • NCT NCT05462730
Other papers using this trial's data
  • Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial Infarction: The PULSE-MI Randomized Clinical Trial JAMA cardiology, 2024-10-01 DOI, PubMed 39211964, PMC11365011 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Denmark (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05462730. Randomized; quadruple masking; primary purpose treatment. Start 2022-11-14 (actual); primary completion 2024-01-30 (actual). Results posted on 2026-03-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction
Acronym
PULSE-MI
Condition
ST Elevation Myocardial Infarction
Condition
Inflammatory Response
Condition
Myocardial Reperfusion Injury
Condition
Myocardial Injury
Intervention (Drug)
Methylprednisolone
Intervention (Drug)
Isotonic saline
Lead sponsor
Thomas Engstrom (class: other)

Record details

Record id
cardio:ct-nct05462730
Content hash
a8d4b7d22354dc762877cb230df19180f01d983e515b8aa0695123621c1d406c